Clinical Trials Browser

Solid Tumors × durvalumab × 1 year × Clear all

NCT04613492 2025-06-24

A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors